Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms [11C]TZ-34125 |
Target |
Action modulators |
Mechanism S1PR2 modulators(Sphingosine 1-phosphate receptor Edg-5 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus | Preclinical | United States | 01 Jul 2023 |





